insights_auto
Prospettive: 37.5% di fonti rialziste·12.5% di fonti ribassiste
Vai all'analisichevron_right
SYK:NYSE
Stryker Corporation
282,60 USD
arrow_upward
+1,92%(+5,32) 1G
284,00 USD
arrow_upward
+0,50% (+1,40)todayPre-market
Chiusura: 12 ott, 16:02:17 GMT-4 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per SYK in corso…
Apertura
277,30 USD
Massimo
283,65 USD
Minimo
274,50 USD
Cap. mercato
108,40 Mld
Vol. medio
2,91 Mln
Volume
1,24K
Dividendo
1,25%
Dividendo trimestrale
0,88 USD
Data di stacco dividendo
30 set 2026
Rapporto P/E
29,28
Max 52 sett.
392,55 USD
Min 52 sett.
267,00 USD
Utili per azione
9,65 USD
Beta
0,77
Azioni in circolazione
383,57 Mln
N. di dipendenti
56K
Apertura
277,30 USD
Massimo
283,65 USD
Minimo
274,50 USD
Cap. mercato
108,40 Mld
Vol. medio
2,91 Mln
Volume
1,24K
Dividendo
1,25%
Dividendo trimestrale
0,88 USD
Data di stacco dividendo
30 set 2026
Rapporto P/E
29,28
Max 52 sett.
392,55 USD
Min 52 sett.
267,00 USD
Utili per azione
9,65 USD
Beta
0,77
Azioni in circolazione
383,57 Mln
N. di dipendenti
56K
Articoli giornalistici
Da fonti web e partner giornalistici
MarketBeat
·
28 minuti fa
Stryker Corporation $SYK Holdings Boosted by Perpetual Ltd
Quiver Quantitative
·
1 ora fa
Fund Update: 336,623 STRYKER (SYK) shares added to Perpetual Ltd portfolio
finchannel
·
3 ore fa
Stryker plans $400 million investment in CMR Surgical
Seeking Alpha
·
4 ore fa
Stryker: Q2 Recovery And Portfolio Expansion Strengthen The Operating Story (NYSE:SYK)
Profilo
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
Informazioni su Stryker Corporation
CEOKevin A. Lobo
Dipendenti56K
Data di fondazione1941
SedeKalamazoo, Michigan, Stati Uniti
Settore-
Sito webstryker.com